Skip to content

Homeopathic medicines for diabetes

A double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines on glycemic control in type II diabetes mellitus in the mutual context of standard care - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066246
Enrollment
140
Registered
2024-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Individualized homoeopathic medicines in centesiml potencies plus standard antidiabetic care: This group will receive homoeopathic medicines plus standard antidiabetic care. Individual
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking, or brushing their teeth

Sponsors

Department of Science and Technology and Biotechnology
Lead Sponsor
D N De Homoeopathic Medical College Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) Cases suffering from diabetes mellitus type II (2021 ICD-10-CM diagnosis code E11.9) 2) FBS more than 126 mg/dl; PPBS more than 200 mg per dl; HbA1c% more than 6.5 (ADA criteria) 3) Age between 18 and 65 years 4) Participants of either sex including transgender 5) Literate patients; ability to read and write in Bengali and/or English

Exclusion criteria

Exclusion criteria: 1) Excessive blood glucose, FBS more than 300 mg per dl, PPBS more than 450 mg per dl 2) Participants with type I DM 3) Diagnosed cases of unstable psychiatric illness or other uncontrolled or life threatening illness affecting the quality of life or any organ failure 4) Pregnant, puerperal, and lactating women 5) Self-reported immune-compromised state 6) Tobacco, alcohol, or any kind of substance abuse and/or dependence 7) Undergoing homoeopathic treatment for any chronic disease within last 6 months 8) Participants denying written informed consent

Design outcomes

Primary

MeasureTime frame
Blood glycosylated hemoglobin percentage (HbA1c%)Timepoint: Baseline, after 3 months, and after 6 months

Secondary

MeasureTime frame
Diabetes Symptom Checklist: Revised (DSC-R) scoreTimepoint: Baseline, then every month, up to 6 months;Fasting blood sugar (FBS)Timepoint: Baseline, then every month, up to 6 months;Lipid profile (triglyceride, total cholesterol, HDL, LDL, VLDL)Timepoint: Baseline, then after 3 months, and after 6 months;Post-prandial blood sugar (PPBS)Timepoint: Baseline, then every month, up to 6 months;Serum Urea, Creatinine, Uric acidTimepoint: Baseline, then after 3 months, and after 6 months;Urine routine and microscopyTimepoint: Baseline, then after 3 months, and after 6 months

Countries

India

Contacts

Public ContactSoumya Bhattacharyya

D N De Homoeopathic Medical College and Hospital

soumya.bh@gmail.com9836998171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026